Search

Your search keyword '"Intrahepatic cholangiocarcinoma"' showing total 1,913 results

Search Constraints

Start Over You searched for: Descriptor "Intrahepatic cholangiocarcinoma" Remove constraint Descriptor: "Intrahepatic cholangiocarcinoma" Topic medicine.disease Remove constraint Topic: medicine.disease
1,913 results on '"Intrahepatic cholangiocarcinoma"'

Search Results

1. Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population-based cancer registries

2. Disseminated Carcinomatosis of Bone Marrow as the Initial Presentation of Intrahepatic Cholangiocarcinoma without Jaundice: An Autopsy Case Report

3. Liver Transplantation for Intrahepatic Cholangiocarcinoma: Ready for Prime Time?

4. Globo H Is a Promising Theranostic Marker for Intrahepatic Cholangiocarcinoma

5. Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second‐line clinical trials

6. Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma

7. Patch venoplasty for resecting tumor invading the retrohepatic inferior vena cava using total and selective hepatic vascular exclusion

8. Combined arterial and delayed enhancement patterns of MRI assist in prognostic prediction for intrahepatic mass-forming cholangiocarcinoma (IMCC)

9. Genetic, Clinicopathological, and Radiological Features of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern

10. Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma

11. Expression of Tspan8 in Patients with Intrahepatic Cholangiocarcinoma and Its Relationship with Clinicopathological Features and Prognosis

12. Isolated liver metastasis detected 11 years after the curative resection of rectal cancer: A case report

13. Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics

14. Inhibin-positive hepatic carcinoma: proposal for a solid-tubulocystic variant of intrahepatic cholangiocarcinoma

15. The prognostic role of tumor-associated unilateral portal vein occlusion in perihilar cholangiocarcinoma

16. Distinct Immune Signatures in Peripheral Blood Predict Chemosensitivity in Intrahepatic Cholangiocarcinoma Patients

17. Liver Transplantation for Intrahepatic Cholangiocarcinoma: A Meta-analysis and Meta-regression of Survival Rates

18. Effect of stereotactic body radiotherapy on regional metabolic liver function investigated in patients by dynamic [18F]FDGal PET/CT

19. Intrahepatic Cholangiocarcinoma Coexisting With Multiple Bile Duct Adenoma Treated as Liver Metastasis from a Pancreatic Neuroendocrine Tumor

20. Indeterminate liver lesions on gadoxetic acid-enhanced magnetic resonance imaging of the liver: Case-based radiologic-pathologic review

21. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States

22. Differences of intraoperative outcomes and postoperative complications between intrahepatic cholangiocarcinoma and colorectal liver metastasis in different surgical methods

23. Maffucci Syndrome with Intrahepatic Cholangiocarcinoma: A Case Report

24. Proposed modification of the eighth edition of the AJCC staging system for intrahepatic cholangiocarcinoma

25. Oncological outcomes of surgery for recurrent biliary tract cancer: who are the best candidates?

26. Liver transplantation in malignant disease

27. Clinical Staging of Mass‐Forming Intrahepatic Cholangiocarcinoma: Computed Tomography Versus Magnetic Resonance Imaging

28. Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death‐Ligand 1 Blockade Responses

29. Perioperative and oncologic outcomes of right anterior sectionectomy for liver disease: A single‐center experience with 415 patients

30. Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence?

31. Chemotherapy with gemcitabine for unresectable intrahepatic cholangiocarcinoma in a patient undergoing maintenance hemodialysis

32. DNA methylation biomarkers for diagnosis of primary liver cancer and distinguishing hepatocellular carcinoma from intrahepatic cholangiocarcinoma

33. Relationship between PD-L1 expression, CD8+ T-cell infiltration and prognosis in intrahepatic cholangiocarcinoma patients

34. Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing Patterns

35. Extent of Lymph Node Dissection for Accurate Staging in Intrahepatic Cholangiocarcinoma

36. Prediction of mismatch repair deficient biliary tract cancer: Role of morphological features and host immune response detected by routine hematoxylin‐eosin staining

37. Combination of albumin-globulin score and skeletal muscle index predicts long-term outcomes of intrahepatic cholangiocarcinoma patients after curative resection

38. Expanding indications for liver transplantation in the era of liver transplant oncology

39. Success rate of microsatellite instability examination and complete response with pembrolizumab in biliary tract cancer

40. Significance of Carbohydrate Antigen 19-9 as a biomarker in Hepatocellular Carcinoma and Cholangiocarcinoma

41. A new pathological classification of intrahepatic cholangiocarcinoma according to protein expression of SSTR2 and Bcl2

42. Rare DNA Mismatch Repair-Related Protein Loss in Patients with Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma and Their Response to Immunotherapy

43. Dynamic 18F-FDG PET imaging of liver lesions: evaluation of a two-tissue compartment model with dual blood input function

44. The strength of cytomorphology and efficacy of immuno‐cytochemistry in distinguishing hepatocellular carcinoma from its mimics on fine‐needle aspiration cytology

45. Lymphoepithelioma-like Intrahepatic Cholangiocarcinoma Is a Distinct Entity With Frequent pTERT/TP53 Mutations and Comprises 2 Subgroups Based on Epstein-Barr Virus Infection

46. Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes

47. Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma

48. Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma

49. Differentiation of hepatocellular carcinoma from intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in high-risk patients matched to MR field strength: diagnostic performance of LI-RADS version 2018

50. Mutational spectrum and precision oncology for biliary tract carcinoma

Catalog

Books, media, physical & digital resources